Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04953195Phase 4Unknown
Phase 4, open-label, single-arm trial of levothyroxine sodium in hypothyroidism, sponsored by Beijing Chaoyang Hospital. Primary endpoints: Thyroid Stimulating Hormone at 12 weeks, Free Thyroxine at 12 weeks and 2 more. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04953195.